Conditional Recommendations Rule in New SARD ILD Guidelines

In spring 2024, the ACR is expected to release guidelines to help inform the screening, monitoring, and treatment of interstitial lung disease (ILD) in people with SARDs.

Related Keywords

New York , United States , Toronto , Ontario , Canada , Elanaj Bernstein , Bristol Myers Squibb , Sindhur Johnson , American College Of Rheumatology , Arthritis Care Research , Boehringer Ingelheim , Pfizer , University Of Toronto , Toronto Scleroderma Program , Presbyterian Scleroderma Center , American College , New York Presbyterian Scleroderma Center , Arthritis Care , Recommendations Assessment , Scleroderma , Crest Syndrome , Clinical Guidelines , Guidelines , Biologic Therapy , Interstitial Lung Disease , Lung , Transplantation Lung , Ulmonary Transplantation , Ransplantation Pulmonary , Lung Transplantation , Otolaryngology , Nt Ears , Nose , Throat , Pulmonary Function Testing , Spirometry , Ankylosing Spondylitis , Antineoplastic Drug , Nti Cancer Agents , Evacizumab , Rlotinib , Efitinib , Matinib , Hi ,